Date: 2024/11/03 - 00:50
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect the heart. However, certain doses and delivery systems can lead to side effects affecting the gut.
Standing more does not improve heart health compared with sitting and may increase a person's risk for circulatory issues such as deep vein thrombosis and varicose veins, a new study finds.
A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a second phase that aggressively damages the brain.
A recent study has, for the first time, looked at how hormonal intrauterine device (IUD) use can affect a person's risk of breast cancer.
The risk of developing type 2 diabetes, stroke, and depression may be higher in people with a "sweet tooth" who prefer sugary foods, new research suggests.
A six-week treatment of chemotherapy before chemoradiotherapy could improve survival rates in people with cervical cancer, results of a phase 3 clinical trial suggest.
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows.
Sleep quality issues in early middle-age are associated with accelerated brain aging and cognitive problems later in life, according to new research.
Vigorous exercise can help with weight loss by lowering levels of the 'hunger hormone' ghrelin, particularly in women, a small new study has found.
Certain genes influence the volume of key brain regions, which, in turn, could play a role in the development of Parkinson's disease and ADHD, a new study suggests.